Harvard Bioscience (HBIO) Work In Process (2011 - 2026)

Harvard Bioscience (HBIO) has 16 years of Work In Process data on file, last reported at $3.4 million in Q1 2026.

• On a quarterly basis, Work In Process rose 11.4% year-over-year to $3.4 million in Q1 2026; TTM through Mar 2026 was $3.4 million, a 11.4% increase from a year earlier, with the FY2025 full-year figure at $3.3 million, up 18.45% from the prior year.
• Work In Process for Q1 2026 stood at $3.4 million, up from $3.3 million in the prior quarter.
• Over the last five years, Work In Process for HBIO reached as high as $4.6 million in Q3 2023 and fell as low as $1.6 million in Q2 2025.
• Historically, Work In Process has averaged $3.4 million across 5 years, with a median of $3.4 million in 2022.
• Across the five-year window, Work In Process rose 20.7% in 2023 and sank 52.79% in 2025, its largest moves.
• Year by year, Work In Process stood at $3.8 million in 2022, then climbed by 10.91% to $4.2 million in 2023, then slumped by 34.24% to $2.8 million in 2024, then advanced by 18.45% to $3.3 million in 2025, then advanced by 3.03% to $3.4 million in 2026.
• Per Business Quant data, the three most recent Work In Process figures were $3.4 million in Q1 2026, $3.3 million in Q4 2025, and $2.3 million in Q3 2025.